1887

Abstract

Polymyxin B (PMB) is a cationic cyclic peptide that can selectively inhibit the growth of Gram-negative bacteria by disrupting the outer membrane permeability barrier through binding to lipopolysaccharide (LPS). Here, a fluorescent PMB derivative (PMB-Ds) was applied to visually confirm the vacuole as a direct lethal target of PMB against fungal cells, which lack LPS. PMB-Ds could be visualized in the normal rounded vacuolar membrane of cells, suggesting the presence of a molecular ligand assisting the vacuole-targeting mobilization of the peptide in the organism. Vma1p, a cytoplasmic subunit constituent of the yeast vacuolar-type ATPase, was identified as one of the PMB-binding proteins by means of mass spectrometry. Mutant cells carrying a deletion of Vma1p but not those with deletions in two separate PMB-binding proteins were shown to be resistant to the vacuolar membrane disruptive action of PMB. Furthermore, the mutant cells were resistant to PMB lethality even when treated with PMB in combination with allicin, an allyl sulfur compound, which can selectively enhance the vacuole-targeting fungicidal activity of the peptide. In contrast, the parent cells were not made resistant to the vacuolar membrane disruptive action of PMB even if cells were pre-treated with bafilomycin A1, a specific inhibitor of the yeast vacuolar-type H-ATPase. However, the parent cells were rendered more resistant to PMB consequent to Vma1p-GFP localization in the cytoplasm. These findings suggested a role for Vma1p in the vacuole-targeting fungicidal activity of PMB comparable to that of LPS in the outer membrane of Gram-negative bacteria.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000450
2017-04-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/micro/163/4/531.html?itemId=/content/journal/micro/10.1099/mic.0.000450&mimeType=html&fmt=ahah

References

  1. Kadar B, Kocsis B, Nagy K, Szabo D. The renaissance of polymyxins. Curr Med Chem 2013; 20:3759–3773 [View Article][PubMed]
    [Google Scholar]
  2. Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007; 60:1206–1215 [View Article][PubMed]
    [Google Scholar]
  3. Vaara M. Agents that increase the permeability of the outer membrane. Micobiol Rev 1992; 56:395–411
    [Google Scholar]
  4. Daugelavicius R, Bakiene E, Bamford DH. Stages of polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob Agents Chemother 2000; 44:2969–2978 [View Article][PubMed]
    [Google Scholar]
  5. Loutet SA, Valvano MA. Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Front Microbiol 2011; 2:159 [View Article][PubMed]
    [Google Scholar]
  6. Boguslawski G. Effects of polymyxin B sulfate and polymyxin B nonapeptide on growth and permeability of the yeast Saccharomyces cerevisiae. Mol Gen Genet 1985; 199:401–405 [View Article][PubMed]
    [Google Scholar]
  7. Pietschmann S, Hoffmann K, Voget M, Pison U. Synergistic effects of miconazole and polymyxin B on microbial pathogens. Vet Res Commun 2009; 33:489–505 [View Article][PubMed]
    [Google Scholar]
  8. Zhai B, Zhou H, Yang L, Zhang J, Jung K et al. Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect. J Antimicrob Chemother 2010; 65:931–938 [View Article][PubMed]
    [Google Scholar]
  9. Srimal S, Surolia N, Balasubramanian S, Surolia A. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem J 1996; 315:679–686 [View Article][PubMed]
    [Google Scholar]
  10. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006; 10:12–18 [View Article][PubMed]
    [Google Scholar]
  11. Pankey G, Ashcraft D, Kahn H, Ismail A. Time-kill assay and E test evaluation for synergy with polymyxin B and fluconazole against Candida glabrata. Antimicrob Agents Chemother 2014; 58:5795–5800 [View Article][PubMed]
    [Google Scholar]
  12. Ogita A, Nagao Y, Fujita K, Tanaka T. Amplification of vacuole-targeting fungicidal activity of antibacterial antibiotic polymyxin B by allicin, an allyl sulfur compound from garlic. J Antibiot 2007; 60:511–518 [View Article][PubMed]
    [Google Scholar]
  13. Ogita A, Konishi Y, Borjihan B, Fujita K, Tanaka T. Synergistic fungicidal activities of polymyxin B and ionophores, and their dependence on direct disruptive action of polymyxin B on fungal vacuole. J Antibiot 2009; 62:81–87 [View Article][PubMed]
    [Google Scholar]
  14. Borjihan B, Ogita A, Fujita K, Doe M, Tanaka T. The cyclic organosulfur compound zwiebelane A from onion (Allium cepa) functions as an enhancer of polymyxin B in fungal vacuole disruption. Planta Med 2010; 76:1864–1866 [View Article][PubMed]
    [Google Scholar]
  15. Yoshioka M, Yamada K, Yamaguchi Y, Ogita A, Fujita K et al. The fungicidal activity of amphotericin B requires autophagy-dependent targeting to the vacuole under a nutrient-starved condition in Saccharomyces cerevisiae. Microbiology 2016; 162:848–854 [View Article][PubMed]
    [Google Scholar]
  16. Urakawa H, Yamada K, Komagoe K, Ando S, Oku H et al. Structure–activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides. Bioorg Med Chem Lett 2010; 20:1771–1775 [View Article][PubMed]
    [Google Scholar]
  17. Iwaki A, Izawa S. Acidic stress induces the formation of P-bodies, but not stress granules, with mild attenuation of bulk translation in Saccharomyces cerevisiae. Biochem J 2012; 446:225–233 [View Article][PubMed]
    [Google Scholar]
  18. Nikawa J, Yata M, Motomura M, Miyoshi N, Ueda T et al. Ternary complex formation of Ino2p-Ino4p transcription factors and Apl2p adaptin β subunit in yeast. Biosci Biotechnol Biochem 2006; 70:2604–2612 [View Article][PubMed]
    [Google Scholar]
  19. Gietz RD, Woods RA. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol 2002; 350:87–96[PubMed] [CrossRef]
    [Google Scholar]
  20. Christoffers KH, Li H, Keenan SM, Howells RD. Purification and mass spectrometric analysis of the µ opioid receptor. Brain Res Mol Brain Res 2003; 118:119–131 [CrossRef]
    [Google Scholar]
  21. Kato M, Wickner W. Ergosterol is required for the Sec18/ATP-dependent priming step of homotypic vacuole fusion. EMBO J 2001; 20:4035–4040 [View Article][PubMed]
    [Google Scholar]
  22. Vida TA, Emr SD. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 1995; 128:779–792 [View Article][PubMed]
    [Google Scholar]
  23. Anraku Y, Hirata R, Wada Y, Ohya Y. Molecular genetics of the yeast vacuolar H+-ATPase. J Exp Biol 1992; 172:67–81[PubMed]
    [Google Scholar]
  24. Uchida E, Ohsumi Y, Anraku Y. Characterization and function of catalytic subunit alpha of H+-translocating adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. A study with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. J Biol Chem 1988; 263:45–51[PubMed]
    [Google Scholar]
  25. Wang Y, Inoue T, Forgac M. Subunit a of the yeast V-ATPase participates in binding of bafilomycin. J Biol Chem 2005; 280:40481–40488 [View Article][PubMed]
    [Google Scholar]
  26. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 1988; 85:7972–7976 [View Article][PubMed]
    [Google Scholar]
  27. Trilisenko L, Tomashevsky A, Kulakovskaya T, Kulaev I. V-ATPase dysfunction suppresses polyphosphate synthesis in Saccharomyces cerevisiae. Folia Microbiol 2013; 58:437–441 [View Article][PubMed]
    [Google Scholar]
  28. Ogita A, Fujita K, Tanaka T. Enhancing effects on vacuole-targeting fungicidal activity of amphotericin B. Front Microbiol 2012; 3:100 [View Article][PubMed]
    [Google Scholar]
  29. Raynor RL, Zheng B, Kuo JF. Membrane interactions of amphiphilic polypeptides mastoparan, melittin, polymyxin B, and cardiotoxin. Differential inhibition of protein kinase C, Ca2+/calmodulin-dependent protein kinase II and synaptosomal membrane Na,K-ATPase, and Na+ pump and differentiation of HL60 cells. J Biol Chem 1991; 266:2753–2758[PubMed]
    [Google Scholar]
  30. Yutani M, Ogita A, Fujita K, Tanaka T. Generation of novel fungicidal activity by the combined actions of hygromycin B and polymyxin B. Int J Life Sci Med Res 2013; 3:193–199 [View Article]
    [Google Scholar]
  31. Ogita A, Fujita K, Taniguchi M, Tanaka T. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system. Planta Med 2006; 72:1247–1250 [View Article][PubMed]
    [Google Scholar]
  32. Eraso P, Mazón MJ, Portillo F. Yeast protein kinase Ptk2 localizes at the plasma membrane and phosphorylates in vitro the C- terminal peptide of the H+-ATPase. Biochim Biophys Acta 2006; 1758:164–170 [View Article][PubMed]
    [Google Scholar]
  33. Goossens A, de La Fuente N, Forment J, Serrano R, Portillo F. Regulation of yeast H+-ATPase by protein kinases belonging to a family dedicated to activation of plasma membrane transporters. Mol Cell Biol 2000; 20:7654–7661 [View Article][PubMed]
    [Google Scholar]
  34. Smardon AM, Kane PM. Loss of vacuolar H+-ATPase activity in organelles signals ubiquitination and endocytosis of the yeast plasma membrane proton pump Pma1p. J Biol Chem 2014; 289:32316–32326 [View Article][PubMed]
    [Google Scholar]
  35. Schwartz SN, Medoff G, Kobayashi GS, Kwan CN, Schlessinger D. Antifungal properties of polymyxin B and its potentiation of tetracycline as an antifungal agent. Antimicrob Agents Chemother 1972; 2:36–40 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000450
Loading
/content/journal/micro/10.1099/mic.0.000450
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error